Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Thailand Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Thailand will continue to be an attractive location to international drug makers as a result of its growing domestic pharmaceutical market with an ageing population and improving access to healthcare as well as its position as a...
Jan 2015 $ 1295
South Korea Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The domestic pharmaceutical industry will continue to have conflicts with the South Korean government over price controls. As a result of these price controls, growth of the pharmaceutical market will be limited and firms need t...
Jan 2015 $ 1295
Kenya Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: The impending dual epidemic of communicable and non-communicable diseases in Kenya will create business opportunities for multinational drugmakers. Investment into physician and patient education and therefore addressing one of ...
Jan 2015 $ 1295
Global In-Vitro Diagnostics (IVD) Market Report: 2014 Edition
By Koncept Analytics
An in-vitro diagnostic test is performed outside of a human body in an artificial environment (e.g. laboratory). IVD is considered as an essential part of today’s healthcare. The IVD products are broadly divided into three categories: reagen...
Jan 2015 $ 800
Global Acne Treatment Market: Trends and Opportunities (2014-2019)
By Daedal Research
Scope of the report The report titled “Global Acne Treatment Market: Trends and Opportunities (2014-2019)” provides an insight into the acne market with focus on global prescription drugs. The ...
Jan 2015 $ 800
Global Spinal Cord Stimulation Market: Trends & Opportunities (2014-19)
By Daedal Research
Scope of the report The report titled “Global Spinal Cord Stimulation Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of the global Spinal cord Stimulation market (i...
Jan 2015 $ 800
Vietnam Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: With a growing and ageing population, Vietnam plays host to an attractive target for pharmaceutical and healthcare growth. While per capita spending remains low, and current healthcare infrastructure appears strained, access to ...
Jan 2015 $ 1295
Venezuela Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: New trade and cooperative agreements for necessary medicines as well as financial injections into the healthcare system will ease Venezuela's troublesome medicine shortage as well as expand healthcare provision in the short-term...
Jan 2015 $ 1295
Uzbekistan Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Economic growth will allow the Uzbek government to sustain the expansive trend in healthcare investment and expenditure over the next years. Rising wages and private consumption will also contribute to drive pharmaceutical and h...
Jan 2015 $ 1295
Sri Lanka Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Sri Lanka's improvements in healthcare have created stronger commercial opportunities for drugmakers in the country, which is also experiencing an epidemiological shift towards chronic diseases. However, strong reliance on forei...
Jan 2015 $ 1295
Serbia Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The combination of a deteriorating economic outlook, rising political risks and industryspecific challenges place downside pressure on prospects for Serbia's pharmaceutical market. In light of this situation, we do not expect an...
Jan 2015 $ 1295
Portugal Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The Portuguese government measures to reduce public spending on medicines will continue to weigh on the pharmaceutical sector over a multi-quarter horizon, as illustrated by a new cost-containment agreement between the Ministry ...
Jan 2015 $ 1295
Kuwait Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: With some of the largest financial buffers of any GCC member nation, Kuwait is well equipped to insulate health expenditure from the near-term effects of falling oil prices. Accordingly, drugmakers can expect high and rising und...
Jan 2015 $ 1295
Iraq Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The competitiveness of Iraq's pharmaceutical sector, as well as the ability of the government to ramp up healthcare investment, is linked to oil prices and additional foreign investment, which is, in turn, highly dependent on th...
Jan 2015 $ 1295
Greece Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: A distinct escalation in political uncertainty will see continued erosion of public and political support for the implementation of much-needed reforms. In addition, drugmakers will see revenue opportunities constrained as press...
Jan 2015 $ 1295
Chile Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Well into our extended forecast period, market conditions in Chile remain very attractive for multinational drugmakers. Although cost containment and measures to promote the uptake of generics are ongoing, the pace of reform is ...
Jan 2015 $ 1295
US Pharmacy Benefit Management (PBM) Industry Report: 2014 Edition
By Koncept Analytics
In the US, Pharmacy Benefit Management (PBM) deals with the management of prescription drug programs. It acts as an intermediary between health plans, drug companies, retail pharmacies and patients. Initially, PBMs used to process pharmaceutical c...
Jan 2015 $ 800
EU: Vaccines For Human Medicine - Market Report. Analysis and Forecast to 2020
By IndexBox
Prices for this report have been revised as following:Single User License – US$ 1900Enterprise License – US$ 3750Contact ...
Jan 2015 $ 1250
EU: Antisera And Other Blood Fractions - Market Report. Analysis and Forecast to 2020
By IndexBox
Prices for this report have been revised as following:Single User License – US$ 1900Enterprise License – US$ 3750Contact ...
Jan 2015 $ 1250
EU: Antibiotics - Market Report. Analysis and Forecast to 2020
By IndexBox
Prices for this report have been revised as following:Single User License – US$ 1900Enterprise License – US$ 3750Contact ...
Jan 2015 $ 1250
EU: Provitamins And Vitamins - Market Report. Analysis and Forecast to 2020
By IndexBox
Prices for this report have been revised as following:Single User License – US$ 1900Enterprise License – US$ 3750Contact ...
Jan 2015 $ 1250
Voglibose - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jan 2015 $ 600
Ocriplasmin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jan 2015 $ 600
Teduglutide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jan 2015 $ 600
Macitentan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jan 2015 $ 600
Live Chat
Live Chat by Comm100